Footer

    Edwyn
    Edwyn

    Conduct a professional comparative analysis in seconds. Empowering your financial decisions with data-driven insights.

    Subscribe to our newsletter

    The latest financial trends, sent to your inbox weekly.

    Products

    • Stock Comparisons
    • Enterprise Value Tool
    • EDGAR Database

    Guides

    • What is Enterprise Value?
    • How much is my company worth?

    Company

    • About
    • Contact us
    • Register

    Legal

    • Privacy
    • Terms

    © Edwyn, LLC. All rights reserved.

    Edwyn logo

    Edwyn

    Contact usWhat is Enterprise Value?Advanced EV Calculator
    CVS HEALTH Corp (CVS)
    Add to EV Report
    Compare CVS
    Income
    Balance Sheet
    Edwyn logo

    Edwyn

    Tesla vs GMApple vs MicrosoftNvidia vs AMD
    NVDATSLAAAPL
    EV Demo
    Log in
    Edwyn logo

    Edwyn

    Find Companies
    Find Companies
    EV ReportCompare Stocks
    Companies, tickers…⌘ K
    Try EV demoCompare Stocks
    Log in
    Tesla vs GMApple vs MicrosoftNvidia vs AMD
    EV Demo
    NVDATSLAAAPL
    Log in to save
    Latest price
    $76.83
    1.87%
    Dollar Amounts
    USD (Millions)
    Metric20202021202220232024
    Revenue$268,706$292,111$322,467$357,776$372,809
    Gross Profit$104,725$116,308$125,575$140,678$166,522
    Operating Income$13,911$13,193$7,746$13,743$8,516
    Net Income$7,179$7,910$4,149$8,344$4,614
    Data source10-K10-K10-K10-K10-K
    Showing latest financials
    Data in millions of USD
    Doing some research...

    Commentary on CVS HEALTH CORPORATION Performance

    Over the past five years, CVS Health has demonstrated steady revenue growth, increasing from approximately $268.7 billion in 2020 to $372.8 billion in 2024. This consistent upward trend reflects the company's expanding market presence in the healthcare and pharmacy retail space. Gross profit similarly shows an improving trajectory, rising from $104.7 billion in 2020 to $166.5 billion in 2024, with 2024 marking an 18% jump from the previous year. This could suggest enhanced operational efficiency, cost management, or a shift toward higher-margin products or services. However, while both revenue and gross profit have generally increased, profitability at the operating level and on the bottom line presents more volatility. Operating income experienced a marked swing. After standing at $13.9 billion in 2020 and a slight dip to $13.2 billion in 2021, it declined significantly to about $7.7 billion in 2022—a drop exceeding 40%—before rebounding to $13.7 billion in 2023 and then declining again to $8.5 billion in 2024. Net income exhibits a similar pattern: it rose from $7.2 billion in 2020 to $7.9 billion in 2021, fell sharply to $4.1 billion in 2022 (a nearly 48% decrease), then jumped to $8.3 billion in 2023, only to retreat to $4.6 billion in 2024. These significant year-over-year swings in operating and net income likely reflect cost fluctuations, pricing adjustments, or changes in the product and service mix rather than revenue issues. Overall, despite strong top-line performance and improving gross margins, the volatility in profitability metrics suggests underlying challenges in maintaining consistent operational efficiency and cost control, which are crucial for sustained financial health in the competitive healthcare sector.

    This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.